In the Press
Researchers identify biomarkers associated with chronic fatigue syndrome severity
Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure.
Researchers at the Stanford University School of Medicine have linked chronic fatigue syndrome to variations in 17 immune-system signaling proteins, or cytokines, whose concentrations in the blood correlate with the disease’s severity.
The findings provide evidence that inflammation is a powerful driver of this mysterious condition, whose underpinnings have eluded researchers for 35 years.
Study finds brain abnormalities in chronic fatigue patients
Radiology researchers have discovered that the brains of patients with chronic fatigue syndrome have diminished white matter and white matter abnormalities in the right hemisphere.
Michael Zeineh and his colleagues studied the brains of patients with chronic fatigue syndrome and healthy people, and found distinct differences between the two groups.
Norbert von der Groeben
An imaging study by Stanford University School of Medicine investigators has found distinct differences between the brains of patients with chronic fatigue syndrome and those of healthy people.
The findings could lead to more definitive diagnoses of the syndrome and may also point to an underlying mechanism in the disease process.
Stanford's Dr. Jose Montoya on Chronic Fatigue Syndrome
Stanford Health Library presents a talk featuring Dr. Jose Montoya, one of the world's leading specialists on chronic fatigue syndrome (CFS). CFS is a disorder which causes extreme fatigue that is unchanged with rest, and interferes with one's ability to attend to daily activities.
This talk features discussion about CFS and current research regarding diagnosis and treatment, and the possible CFS-infection connection.
Speaker: Jose G. Montoya, MD, Associate Professor of Medicine, Division of Infectious Diseases.
Watch this YouTube video featuring Dr. Montoya (1 hour, 13 minutes):
Demystifying chronic fatigue syndrome
Ruthann Richter on November 8, 2017
For years, infectious disease expert Jose Montoya, MD, has been frustrated by the mysteries of chronic fatigue syndrome (also known as myalgic encephalomyelitis) and the unexplainable and often debilitating symptoms of the many patients who come through his clinic at Stanford. But earlier this year, Montoya’s perseverance was rewarded and his optimism soared following a seven-year study he led that showed that the disease has a clear link to 17 immune system proteins, including 13 proteins that are pro-inflammatory.
This proved what scientists had suspected — that inflammation is the prime driver behind the disease, which affects between one and four million people, often with devastating effects. When the finding first came to light, Montoya told me he was “ecstatic.”
Scientists Edge Closer To Elusive Lab Test For Chronic Fatigue Syndrome
By Miriam E. Tucker
July 31, 2017
Imagine feeling horribly sick, day after day, yet doctors repeatedly tell you they can't find anything wrong. That typically happens to people with the mysterious illness commonly known as chronic fatigue syndrome. Research findings from Stanford University released Monday could point the way to a long-sought diagnostic laboratory test for the condition, and possibly a first-ever treatment.
Believed to affect at least a million people in the U.S., the condition is now increasingly termed myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS for short.
Many patients see the name "chronic fatigue syndrome" as trivializing and misleading, giving the impression that they're simply tired or depressed. In fact, they're experiencing profound exhaustion that isn't relieved with sleep, flu-like symptoms, muscle pain, "brain fog" and various other physical symptoms, all of which characteristically worsen with even minor exertion. (A 2015 Institute of Medicine report proposed the name "systemic exertion intolerance disease," but it hasn't really stuck.)
Read more: NPR's Health News
Stanford discovery: Biomarkers linked to Chronic Fatigue Syndrome
Evidence could lead to test for mysterious condition
By Lisa M. Krieger
A new Stanford study has identified biomarkers linked to the severity of chronic fatigue syndrome, offering evidence that inflammation is a powerful driver of this mysterious disease, long dismissed as a psychological condition.
The team, led Dr. Jose Montoya of Stanford University School of Medicine, found that varying concentrations of 17 immune-system signaling proteins, or cytokines, in the blood correlate with the disease’s severity.
The underpinnings of the disease have eluded researchers for 35 years. Patients experience debilitating fatigue, often unable to walk, talk or even eat.
Read more: Take me to Mercury News
Is This Why You're Still So Tired?
Chronic fatigue syndrome finally gets its due.
By Cheryl Platzman Weinstock
Eight years ago, Ann Cavanagh Kramer was promoted to director of commercial sales at Visa. She transferred across the country to work at the company's San Francisco Bay Area office and spent the next six months traveling to attend conferences and meet potential clients. She was, in her own words, "at the top of my game." But after running a half marathon in October 2007, she suffered back-to-back viral infections. Then she began experiencing dizzy spells and fatigue so intense, she'd sleep for 15 to 16 hours a day. "When I wasn't working, I was sleeping," says Cavanagh Kramer, 38. She thought she might have a sinus infection, bronchitis, or the flu. Or maybe pneumonia. "No one could figure out what was wrong with me."
Read more: http://www.oprah.com/health_wellness/chronic-fatigue-syndrome#ixzz4qbffO2Vr
Is chronic fatigue syndrome finally being taken seriously?
Once dismissed by many doctors as a psychological illness, new research suggests CFS has its roots in infection – and there is hope of successful treatment
By David Cox
Jose Montoya was a trainee doctor when his supervisor told him that if he continued specialising in treating chronic fatigue syndrome (CFS), he would end up homeless. “About 15 years ago, I started working with 10 patients who’d had their lives devastated by this illness,” says Montoya, now a professor at Stanford University and one of the world’s leading experts on the disease. “I had been able to help them, so I took my results to my academic mentor and he told me: ‘You are committing academic suicide. You’re turning your career into a mess.’”
Chronic fatigue syndrome is a physical disorder,
not a psychological illness, panel says
By Lenny Berstein
Chronic fatigue syndrome is a "serious, debilitating" condition with a cluster of clear physical symptoms — not a psychological illness — a panel of experts reported Tuesday as it called for more research into a disease that may affect as many as 2.5 million Americans.
"We just needed to put to rest, once and for all, the idea that this is just psychosomatic or that people were making this up, or that they were just lazy," said Ellen Wright Clayton, a professor of pediatrics and law at Vanderbilt University, who chaired the committee of the Institute of Medicine, the health arm of the National Academy of Sciences.
Read more at The Washington Post
Stanford leads fight against chronic fatigue
Kelsey Vischer spent much of her teen years playing sports and performing in an Irish dance troop. But on the verge of leaving for college, her active life suddenly came to a screeching halt. That's when a case of mono evolved into a grueling battle against exhaustion.
"I couldn't get off the couch. My dad had to pick me up off the couch and carry me to the bathroom. It was very intense," Kelsey remembers.
Kelsey was finally directed to Jose Montoya, M.D., at Stanford's Chronic Fatigue clinic.
The clinic is dedicated to treating a condition that skeptics have challenged as not being a real disease.
New technology could help doctors ID chronic fatigue syndrome in patients
By Cheryl Jennings
Endurance was never a problem for Ann Kavanagh-Kramer. For years she competed in long-distance runs from California to Europe.
Then, at age 30 her health suddenly changed.
"That was the hardest time, when I couldn't get out of bed," Kavanagh-Kramer said. "At times I was crawling to use the bathroom."
She went from doctor to doctor for months searching for the cause of her fatigue. Without a diagnosis she would eventually undergo a battery of tests just to prove she was sick-enough to be placed on disability.
"I was called a hypochondriac in the early days. I was told I needed to go to physical therapy," she said.
Cavanaugh-Kramer finally turned to doctor Jose Montoya at Stanford's Chronic Fatigue Clinic. He diagnosed her condition as chronic fatigue syndrome, or CFS.
Read more on ABC 7's newspage
Fatigue syndrome validated by influential group
By Erin Allday
Chronic fatigue syndrome is a real disease that can devastate patients’ lives, leaving them bed-bound and barely able to think clearly, and it requires serious treatment and speedy diagnosis, according to a report released Tuesday by the influential and widely respected Institute of Medicine.
The report also suggested a new name for the syndrome: systemic exertion intolerance disease. Patients with the disease and medical experts were skeptical of the name, but many otherwise heralded the long-anticipated report.
“The Institute of Medicine was able to come out and say this is real, it’s chronic and it devastates many lives,” said Dr. Jose Montoya, an infectious disease specialist who helped establish a chronic fatigue syndrome team at Stanford University a decade ago. “For 30 years very few voices were saying that and people were not listening. And now here comes an institute with such visibility and clout, saying those words.”
The report “has the potential to change the narrative of this disease,” Montoya said.
Chronic fatigue patients frustrated with FDA
By Erin Allday
Jeannette Burmeister lives in Incline Village, Nev., where, twice a week, she gets a three-hour infusion of a drug to treat chronic fatigue syndrome that she says has very nearly saved her life.
But it comes at a steep price: Burmeister's husband and her 2-year-old daughter live more than 200 miles away in Menlo Park, and she's able to see them only once a week. Because the drug she says she needs - an experimental medication called Ampligen - isn't approved by the Food and Drug Administration, the only way she can get it is through a clinical trial run by a doctor in Nevada.
And as of this month, when the FDA officially refused to approve Ampligen for treatment of chronic fatigue, she's not sure how much longer she'll be able to get the drug.